Attend the 2016 ASH Meeting on Hematologic Malignancies to hear world-class experts in hematologic malignancies discuss the latest developments in clinical care, and learn how experts in the field treat their own patients based on the available data.
The majority of the program content will be structured as “How I Treat” sessions on core malignancies, including leukemia, lymphoma, myelodysplastic syndromes, myeloma, and myeloproliferative neoplasms. Each presentation will showcase the speaker’s evidence-based treatment approaches, ranging from standard of care, specialized disease complications, and novel agent discussions. The meeting will also feature topic-based panel discussions which will allow participants to get answers to their most challenging patient care questions.
